BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Borovcanin MM, Vesic K, Jovanovic M, Mijailovic NR. Galectin-3 possible involvement in antipsychotic-induced metabolic changes of schizophrenia: A minireview. World J Diabetes 2021; 12(10): 1731-1739 [PMID: 34754374 DOI: 10.4239/wjd.v12.i10.1731]
URL: https://www.wjgnet.com/1948-9358/full/v12/i10/1731.htm
Number Citing Articles
1
Slavica Minic Janicijevic, Ivan P Jovanovic, Nevena M Gajovic, Milena M Jurisevic, Monojit Debnath, Nebojsa N Arsenijevic, Milica M Borovcanin. Galectin-3 mediated risk of inflammation in stable schizophrenia, with only possible secondary consequences for cognitionWorld Journal of Psychiatry 2022; 12(9): 1183-1193 doi: 10.5498/wjp.v12.i9.1183
2
Kah Kheng Goh, Cynthia Yi-An Chen, Tzu-Hua Wu, Chun-Hsin Chen, Mong-Liang Lu. Crosstalk between Schizophrenia and Metabolic Syndrome: The Role of Oxytocinergic DysfunctionInternational Journal of Molecular Sciences 2022; 23(13) doi: 10.3390/ijms23137092
3
Nataša R. Mijailović, Katarina Vesic, Dragana Arsenijevic, Maja Milojević-Rakić, Milica M. Borovcanin. Galectin-3 Involvement in Cognitive Processes for New Therapeutic ConsiderationsFrontiers in Cellular Neuroscience 2022; 16 doi: 10.3389/fncel.2022.923811
4
Nataša R Mijailović, Ivan P Jovanovic, Ivica Petrovic, Katarina Vesic, Milica M Borovcanin. Diabetes mellitus type 2 as an underlying, comorbid or consequent state of mental disordersWorld Journal of Diabetes 2023; 14(5): 481-493 doi: 10.4239/wjd.v14.i5.481
5
Milica M. Borovcanin, Bojan Stojanovic, Milica Dimitrijevic Stojanovic, Bojana S. Stojanovic, Aleksandar Lazovic, Marina Mitrovic. Cancer Treatment Modalities: An Interdisciplinary ApproachInterdisciplinary Cancer Research 2024; 24 doi: 10.1007/16833_2024_394
6
Büşra Sultan Sevindik, Özlem Olguner Eker, Akif Asdemir, Esra Kısacık, Ayşe Işık, Eser Kılıç, Ertuğrul Eşel. Serum Galectin‐1 and Galectin‐3 Levels and Their Relationship With Executive Functions and Memory in Patients With Major Depressive DisorderHuman Psychopharmacology: Clinical and Experimental 2026; 41(4) doi: 10.1002/hup.70052